5 Best New AI Stocks to Buy

2. Doximity, Inc. (NYSE:DOCS)

On March 18, Freedom Capital analyst Gene Mannheimer initiated coverage on Doximity, Inc. (NYSE:DOCS) with a Buy rating and a $31 price target, highlighting the company’s strong network effects, scalable business model, and above-average growth potential. The analyst emphasized that recent share price weakness presents an attractive entry point, suggesting that the market may be underestimating the company’s long-term earnings power.

Earlier, on February 20, Piper Sandler raised its price target on Doximity, Inc. (NYSE:DOCS) to $42 from $40 while maintaining an Overweight rating. The firm pointed to the strength of Doximity’s AI tool suite, particularly DoxGPT, citing its integration within the platform, high-quality clinical outputs, and strong evidence base. These capabilities enhance user engagement and reinforce the company’s competitive positioning in digital healthcare.

Doximity, Inc. (NYSE:DOCS) operates a leading digital platform for medical professionals in the United States, combining professional networking with AI-powered clinical tools. Its offerings help physicians streamline workflows and access high-quality medical information. With increasing adoption of AI in healthcare and strong network effects driving user retention, Doximity is well-positioned to deliver sustained growth, making it a compelling investment opportunity.